MCID: MCR011
MIFTS: 46

Microinvasive Gastric Cancer

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Microinvasive Gastric Cancer

MalaCards integrated aliases for Microinvasive Gastric Cancer:

Name: Microinvasive Gastric Cancer 12
Early Gastric Cancer 12 55 73
Surface Gastric Cancer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10541
NCIt 50 C27131
SNOMED-CT 68 276809004
UMLS 73 C0349530

Summaries for Microinvasive Gastric Cancer

MalaCards based summary : Microinvasive Gastric Cancer, also known as early gastric cancer, is related to tubular adenocarcinoma and mucinous adenocarcinoma, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Microinvasive Gastric Cancer is BCYRN1 (Brain Cytoplasmic RNA 1
XIST, BCYRN1, RRP1B and TDRG1 were identified as differentially expressed in EGC tissues compared with NATs. The specificity and sensitivity of XIST, BCYRN1, RRP1B and TDRG1 were determined by receiver operating characteristic curve analysis. In addition, RRP1B expression was revealed to be significantly correlated with distal metastasis (P=0.020) and tumor?node?metastasis staging (P=0.018), and TDRG1 expression was significantly correlated with lymph node metastasis (P=0.001). Furthermore, BCYRN1, RRP1B and TDRG1 expression levels were compared between EGC tissues and plasma, and the results indicated that there were significant positive correlations of XIST, BCYRN1, RRP1B and TDRG1 expression levels between the EGC tissues and plasma.
Dysfunction Pattern: Expression [differentially expressed]), and among its related pathways/superpathways are Pathways in cancer and Gastric cancer. The drugs Aspirin and Clopidogrel have been mentioned in the context of this disorder. Affiliated tissues include lymph node, liver and b cells, and related phenotype is neoplasm.

Related Diseases for Microinvasive Gastric Cancer

Diseases related to Microinvasive Gastric Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 120)
# Related Disease Score Top Affiliating Genes
1 tubular adenocarcinoma 30.4 CDH1 CDX2 MUC2
2 mucinous adenocarcinoma 30.2 CDX2 MLH1 MUC2
3 papillary adenocarcinoma 29.9 CDH1 CEACAM5 MUC2
4 gastritis 29.1 CDX2 GAST S100A8
5 cholangiocarcinoma 28.8 CDH1 CDX2 CEACAM5 MUC2 VEGFC
6 atrophic gastritis 28.5 CDX2 GAST S100A8
7 esophageal cancer 27.9 BCYRN1 CDH1 CDX2 CEACAM5 TYMP VEGFC
8 gastric cancer 26.8 CDH1 CDX2 CEACAM5 CTNNA1 GAST MLH1
9 mucinous intrahepatic cholangiocarcinoma 10.8 CDX2 MUC2
10 diversion colitis 10.7 CDH1 MUC2
11 ovarian mucinous adenocarcinoma 10.7 CDX2 MUC2
12 chronic cholangitis 10.6 CDX2 MUC2
13 gastric cancer, hereditary diffuse 10.6 CDH1 CTNNA1
14 signet ring cell adenocarcinoma 10.5 CDH1 CDX2 MUC2
15 tongue cancer 10.5 BCYRN1 CDH1 VEGFC
16 anal paget's disease 10.5 CDX2 CEACAM5
17 gastric diffuse adenocarcinoma 10.5 CDH1 CDX2 CTNNA1
18 small intestine cancer 10.5 CDX2 MLH1 MUC2
19 bile duct carcinoma 10.5 CDH1 CDX2 MUC2
20 ampulla of vater neoplasm 10.5 CDX2 MUC2
21 esophageal adenosquamous carcinoma 10.5 CDH1 CEACAM5
22 intrahepatic cholangiocarcinoma 10.5 CDH1 CDX2 MUC2
23 mucinous adenofibroma 10.5 CDX2 CEACAM5
24 anus adenocarcinoma 10.4 CDX2 CEACAM5
25 cervical squamous cell carcinoma 10.4 CDH1 TYMP XIST
26 appendix cancer 10.4 CDX2 MUC2
27 bile duct mucoepidermoid carcinoma 10.4 CEACAM5 MUC2
28 bile duct cystadenocarcinoma 10.3 CEACAM5 MUC2
29 thymus adenocarcinoma 10.3 CDX2 CEACAM5
30 clear cell adenoma 10.3 CEACAM5 MUC2
31 gastric signet ring cell adenocarcinoma 10.3 CDH1 CDX2 CEACAM5
32 vulva adenocarcinoma 10.2 CDX2 CEACAM5
33 biliary papillomatosis 10.2 CDX2 CEACAM5 MUC2
34 superior mesenteric artery syndrome 10.2 CDX2 CEACAM5 MUC2
35 ovarian mucinous neoplasm 10.2 CDX2 CEACAM5 MUC2
36 rectum adenocarcinoma 10.2 CDX2 CEACAM5
37 bile duct adenocarcinoma 10.2 CDH1 CEACAM5 MUC2
38 female reproductive organ cancer 10.1 CDH1 CEACAM5 MLH1
39 mucositis 10.1
40 cell type benign neoplasm 10.1 CEACAM5 MLH1 MUC2
41 colon adenocarcinoma 10.1 CDH1 CEACAM5 MLH1
42 pancreas adenocarcinoma 10.1 CDH1 CEACAM5 MUC2
43 lymphoma 10.0
44 breast adenomyoepithelioma 10.0 CDH1 CEACAM5
45 goblet cell carcinoid 10.0 CDH1 GAST
46 rectal neoplasm 10.0 CEACAM5 MLH1 TYMP
47 adenocarcinoma 10.0
48 situs inversus 10.0
49 ampulla of vater adenocarcinoma 10.0 CDX2 MUC2
50 helicobacter pylori infection 10.0

Graphical network of the top 20 diseases related to Microinvasive Gastric Cancer:



Diseases related to Microinvasive Gastric Cancer

Symptoms & Phenotypes for Microinvasive Gastric Cancer

UMLS symptoms related to Microinvasive Gastric Cancer:


abdominal pain, dyspepsia

MGI Mouse Phenotypes related to Microinvasive Gastric Cancer:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.1 CDH1 CDX2 CTNNA1 GAST MLH1 MUC2

Drugs & Therapeutics for Microinvasive Gastric Cancer

Drugs for Microinvasive Gastric Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 121)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
2
Clopidogrel Approved Phase 4 120202-66-6, 113665-84-2 60606
3
Pantoprazole Approved Phase 4,Not Applicable 102625-70-7 4679
4
Ticlopidine Approved Phase 4 55142-85-3 5472
5
Ecabet Approved, Investigational Phase 4 33159-27-2, 86408-72-2 65781
6
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
7
Rabeprazole Approved, Investigational Phase 4,Phase 3 117976-89-3 5029
8 Analgesics Phase 4,Phase 3,Phase 2,Not Applicable
9 Analgesics, Non-Narcotic Phase 4,Not Applicable
10 Antacids Phase 4,Phase 3,Not Applicable
11 Anti-Inflammatory Agents Phase 4,Not Applicable
12 Anti-Inflammatory Agents, Non-Steroidal Phase 4
13 Antipyretics Phase 4
14 Antirheumatic Agents Phase 4
15 Anti-Ulcer Agents Phase 4,Phase 3,Not Applicable
16 Cyclooxygenase Inhibitors Phase 4
17 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
18 Fibrinolytic Agents Phase 4
19 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
20 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
21 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
22 Platelet Aggregation Inhibitors Phase 4
23 Proton Pump Inhibitors Phase 4,Phase 3,Not Applicable
24 Purinergic P2 Receptor Antagonists Phase 4
25 Purinergic P2Y Receptor Antagonists Phase 4
26 Anti-Infective Agents Phase 4,Phase 3
27 HIV Protease Inhibitors Phase 4,Not Applicable
28
protease inhibitors Phase 4,Not Applicable
29 Protective Agents Phase 4,Not Applicable
30 Anesthetics Phase 4,Phase 3,Not Applicable
31 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
32 Anti-Arrhythmia Agents Phase 4
33 Anticonvulsants Phase 4
34 calcium channel blockers Phase 4
35 Calcium, Dietary Phase 4
36 Tocolytic Agents Phase 4
37
Meperidine Approved Phase 3 57-42-1 4058
38
Midazolam Approved, Illicit Phase 3,Not Applicable 59467-70-8 4192
39
Menthol Approved Phase 3,Not Applicable 2216-51-5 16666
40
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613
41
Clarithromycin Approved Phase 3 81103-11-9 84029
42
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
43 Adjuvants, Anesthesia Phase 3,Not Applicable
44 Analgesics, Opioid Phase 3,Not Applicable
45 Anesthetics, General Phase 3,Not Applicable
46 Anesthetics, Intravenous Phase 3,Not Applicable
47 Anti-Anxiety Agents Phase 3,Not Applicable
48 GABA Agents Phase 3,Not Applicable
49 GABA Modulators Phase 3,Not Applicable
50 Hypnotics and Sedatives Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 84)
# Name Status NCT ID Phase Drugs
1 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
2 Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection Unknown status NCT01308177 Phase 4 Ecabet
3 The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study Completed NCT02235246 Phase 4 Magnesium Sulfate;Normal saline
4 Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Recruiting NCT02638584 Phase 4 Ilaprazole;Rabeprazole
5 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Unknown status NCT01157598 Phase 3
6 Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) Unknown status NCT01609309 Phase 3
7 Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301) Completed NCT00546468 Phase 3
8 Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy Completed NCT01411176 Phase 3 Menthol;Placebo
9 Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases Completed NCT02219529 Phase 3
10 Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy Recruiting NCT02595086 Phase 3
11 Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients Recruiting NCT02246153 Phase 3
12 A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer Recruiting NCT02748551 Phase 3
13 Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy Active, not recruiting NCT01804998 Phase 3
14 Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD Active, not recruiting NCT02407119 Phase 3 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin;Placebo, Omeprazole or Rabeprazole, Clarithromycin
15 The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric Unknown status NCT02694081 Phase 2
16 The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer Completed NCT02347956 Phase 1, Phase 2
17 Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy Completed NCT02522598 Phase 2 VVZ-149 injections;Placebo
18 Laparoscopic Gastrectomy for Advanced Gastric Cancer Completed NCT01441336 Phase 2
19 Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients Recruiting NCT02644148 Phase 2
20 Phase II Study for Robot Assisted Distal Gastrectomy Active, not recruiting NCT01504997 Phase 2
21 Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients Not yet recruiting NCT03564834 Phase 2
22 The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer Unknown status NCT02710838 Not Applicable
23 Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer Unknown status NCT01659632
24 the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer Unknown status NCT02385578 Not Applicable
25 Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer Unknown status NCT01832246
26 Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection Unknown status NCT02189226 Not Applicable
27 Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer Unknown status NCT01132469 Not Applicable
28 Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection Unknown status NCT02037399 Not Applicable intravenous dexamethasone;intravenous normal saline
29 Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection Unknown status NCT02090062
30 Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer Unknown status NCT01774266
31 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Unknown status NCT01813994 Not Applicable Arm1: Statin;Arm2: Placebo
32 The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer Unknown status NCT02243618 Not Applicable Polaprezinc;Rebamipide
33 The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population Unknown status NCT01490541
34 Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With Diabetes Mellitus Unknown status NCT01375738 Not Applicable
35 Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC Unknown status NCT01283893
36 Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer Unknown status NCT01742806 Not Applicable
37 Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial Unknown status NCT01179724 Not Applicable high dose proton pump inhibitor;H2RB
38 PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma Unknown status NCT02515721 Not Applicable
39 The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM) Unknown status NCT01491724
40 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
41 Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients Completed NCT01643811
42 Endoscopic Submucosal Dissection Versus Gastrectomy Completed NCT02216110
43 Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer Completed NCT01544413 Not Applicable
44 Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy Completed NCT00851305 Not Applicable
45 Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer Completed NCT01943253 Not Applicable
46 Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB Completed NCT02738294 Not Applicable
47 Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer Completed NCT01617876
48 Endoscopic Submucosal Dissection (ESD)- Master Slave Robotic System - Human Study Completed NCT01394861 Early Phase 1
49 Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring Completed NCT01921283 Not Applicable no- BIS sensor attachment
50 A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil Completed NCT01920113 Not Applicable Dexmedetomidine - remifentanil group;Propofol - remifentanil group

Search NIH Clinical Center for Microinvasive Gastric Cancer

Genetic Tests for Microinvasive Gastric Cancer

Anatomical Context for Microinvasive Gastric Cancer

MalaCards organs/tissues related to Microinvasive Gastric Cancer:

41
Lymph Node, Liver, B Cells, Endothelial, Thyroid, Cervix, Colon

Publications for Microinvasive Gastric Cancer

Articles related to Microinvasive Gastric Cancer:

(show top 50) (show all 323)
# Title Authors Year
1
Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen. ( 29977284 )
2018
2
Endoscopic submucosal dissection of early gastric cancer via inverted overtube in a patient with situs inversus totalis: a case report. ( 29756022 )
2018
3
Long-term outcomes after noncurative endoscopic resection ofA early gastric cancer: the optimal time for additional endoscopicA treatment. ( 29031882 )
2018
4
The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: aA systematic review of the literature and meta-analysis. ( 28966062 )
2018
5
The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer. ( 28484889 )
2018
6
Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer. ( 29330205 )
2018
7
Serial intermediate-term quality of life comparison after endoscopic submucosal dissection versus surgery in early gastric cancer patients. ( 29067581 )
2018
8
Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissection. ( 28840337 )
2018
9
Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab. ( 29978335 )
2018
10
The Value of Computed Tomography in Preoperative N Staging of Early Gastric Cancer Meeting the Endoscopic Resection Criteria. ( 28934832 )
2017
11
Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer with Undifferentiated-Type Histology: A Clinical Simulation Using a Non-Selected Surgical Cohort. ( 29271182 )
2017
12
Expressions of Ras Homolog Gene Family, Member A (RhoA) and Cyclooxygenase-2 (COX-2) Proteins in Early Gastric Cancer and Their Role in the Development of Gastric Cancer. ( 28624843 )
2017
13
Diagnostic accuracy of demarcation of undifferentiated-type early gastric cancer after Helicobacter pylori eradication. ( 28083659 )
2017
14
Potential lncRNA diagnostic biomarkers for early gastric cancer. ( 29039538 )
2017
15
The Characteristics and Prognosis of Diffuse-Type Early Gastric Cancer Diagnosed during Health Check-Ups. ( 28798286 )
2017
16
Magnifying Blue Laser Imaging versus Magnifying Narrow-Band Imaging for the Diagnosis of Early Gastric Cancer: A Prospective, Multicenter, Comparative Study. ( 28848169 )
2017
17
Familial Adenomatous Polyposis with Multiple Helicobacter-negative Early Gastric Cancers Treated by Endoscopic Submucosal Dissection. ( 29021452 )
2017
18
The Frequency and Risk Factors of Colorectal Adenoma in Patients with Early Gastric Cancer. ( 28675538 )
2017
19
MicroRNAa89499 rs3746444 A/G polymorphism functions as a biomarker to predict recurrence following endoscopic submucosal dissection in primary early gastric cancer. ( 28339066 )
2017
20
The Rs4938723 Polymorphism Reduces Expression of MicroRNA-34b and Increases the Risk of Recurrence after Endoscopic Dissection in Early Gastric Cancer. ( 28977792 )
2017
21
Predictive value for lymph node metastasis of epithelial-mesenchymal transition and cancer stem cell marker expression in early gastric cancer. ( 28595915 )
2017
22
Development of an e-learning system for teaching endoscopists how to diagnose early gastric cancer: basic principles for improving early detection. ( 28032233 )
2017
23
Gastric neuroendocrine tumor mimicking early gastric cancer. ( 28478029 )
2017
24
Endoscopic resection versus radical gastrectomy for early gastric cancer in Asia: A meta-analysis. ( 28987558 )
2017
25
Expression of macrophage inhibitory cytokine-1 in early gastric cancer cases treated using endoscopic mucosal resection and the correlation with prognosis. ( 28789430 )
2017
26
Double Endoscopic Intraluminal Operation (DEILO) for Early Gastric Cancer: Outcome of Novel Procedure for Endoscopic Submucosal Dissection. ( 28011512 )
2017
27
Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers. ( 28843920 )
2017
28
Delayed perforation occurring on the 24th day after endoscopic submucosal dissection for early gastric cancer. ( 28004249 )
2017
29
Multi-disciplinary team for early gastric cancer diagnosis improves the detection rate of early gastric cancer. ( 29212444 )
2017
30
Management of early gastric cancer that meet the indication for radical lymph node dissection following endoscopic resection: a retrospective cohort analysis. ( 28637436 )
2017
31
Expression of microRNA-328 Functions as a Biomarker for Recurrence of Early Gastric Cancer (EGC) After Endoscopic Submucosal Dissection (ESD) by Modulating CD44. ( 27923017 )
2016
32
Important considerations when contemplating endoscopic resection of undifferentiated-type early gastric cancer. ( 26811655 )
2016
33
Hand-assisted laparoscopic spleen-preserving distal pancreatectomy combined with laparoscopic distal gastrectomy for the treatment of pancreatic neuroendocrine tumor with early gastric cancer: Report of a case. ( 27756027 )
2016
34
Endoscopic resection of early gastric cancer: current status and new approaches. ( 28138591 )
2016
35
[Detection of early gastric cancer facilitated by surveillance for a pyogenic liver abscess caused by Streptococcus intermedius]. ( 26853986 )
2016
36
Long-term prognosis after endoscopic submucosal dissection for early gastric cancer in super-elderly patients. ( 26850026 )
2016
37
Magnifying Endoscopy with Narrow Band Imaging of Early Gastric Cancer: Correlation with Histopathology and Mucin Phenotype. ( 27021504 )
2016
38
Evaluation of the Diagnostic Ability of Optical Enhancement System in Early Gastric Cancer Demarcation. ( 27774101 )
2016
39
Totally laparoscopic gastrectomy for early gastric cancer accompanied by huge hiatal hernia: A case report. ( 26781529 )
2016
40
Laparoscopic versus open distal gastrectomy for early gastric cancer in Japan: long-term clinical outcomes of a randomized clinical trial. ( 26223834 )
2016
41
Additional surgical resection after endoscopic mucosal dissection for early gastric cancer: A medium-sized hospital's experience. ( 27871804 )
2016
42
Clinicopathologic Similarities of the Main and Minor Lesions of Synchronous Multiple Early Gastric Cancer. ( 27247495 )
2016
43
CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer. ( 25779358 )
2016
44
Diagnosis of Helicobacter pylori-related chronic gastritis, gastric adenoma and early gastric cancer by magnifying endoscopy. ( 27577845 )
2016
45
Should an Aberrant Left Hepatic Artery Arising from the Left Gastric Artery Be Preserved during Laparoscopic Gastrectomy for Early Gastric Cancer Treatment? ( 27433391 )
2016
46
Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer. ( 26884381 )
2016
47
Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation. ( 27688662 )
2016
48
Early Gastric Cancer: Trends in Incidence, Management, and Survival in a Well-Defined French Population. ( 27216743 )
2016
49
Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer. ( 27482895 )
2016
50
Gastric hyperplastic polyps coexisting with early gastric cancers, adenoma and neuroendocrine cell hyperplasia. ( 27179272 )
2016

Variations for Microinvasive Gastric Cancer

Expression for Microinvasive Gastric Cancer

Search GEO for disease gene expression data for Microinvasive Gastric Cancer.

Pathways for Microinvasive Gastric Cancer

GO Terms for Microinvasive Gastric Cancer

Cellular components related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell-cell adherens junction GO:0005913 9.54 CDH1 CTNNA1 JUP
2 adherens junction GO:0005912 9.5 CEACAM1 CTNNA1 JUP
3 flotillin complex GO:0016600 9.26 CDH1 CTNNA1
4 zonula adherens GO:0005915 9.16 CTNNA1 JUP
5 lateral plasma membrane GO:0016328 9.13 CDH1 CEACAM1 JUP
6 catenin complex GO:0016342 8.8 CDH1 CTNNA1 JUP
7 extracellular region GO:0005576 10.01 CDH1 CEACAM1 CEACAM5 GAST JUP PSG2

Biological processes related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of cell-matrix adhesion GO:0001954 9.16 JUP VEGFC
2 adherens junction organization GO:0034332 9.13 CDH1 CTNNA1 JUP
3 cellular response to indole-3-methanol GO:0071681 8.8 CDH1 CTNNA1 JUP

Molecular functions related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein homodimerization activity GO:0042803 9.1 CDH1 CEACAM1 CEACAM5 CHKA JUP TYMP
2 gamma-catenin binding GO:0045295 8.96 CDH1 CTNNA1

Sources for Microinvasive Gastric Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....